The abstract is read at the publisher; the summary is JClub's.
Protein kinase C (PKC) agonists are promising candidates in HIV cure research because they can reactivate latent HIV reservoirs and potentially promote clearance.
- Why it matters: Despite effective antiretroviral therapy (ART), HIV remains a worldwide health concern, motivating new therapeutic and cure strategies targeting latent infection.
- What they did: This review summarizes current knowledge on PKC agonists’ mechanisms, their impact on HIV reservoirs, and how they might be integrated into a functional cure approach.
- The result: The evidence discussed suggests PKC agonists are a compelling direction for HIV cure research, while highlighting difficulties that require additional research to advance their use.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.